Letters to Venture Capital Firms on Funding Problematic PRC Companies - Select Committee on the CCP | (.gov)

On July 19, 2023, the House Select Committee on the Chinese Communist Party issued formal letters to four prominent U.S. venture capital firms, signaling heightened congressional concern over venture capital funding flowing into Chinese technology companies with potential national security implications. The bipartisan action, led by Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL), targets GGV Capital, GSR Ventures, Qualcomm Ventures, and Walden International, demanding detailed disclosure of their investments in Chinese artificial intelligence, semiconductor, and quantum computing firms.

The Committee's investigation centers on the weaponization risk of U.S. capital and technical expertise. According to the primary source material, the PRC is actively deploying AI advancements to perpetrate human rights abuses and enhance military capabilities, while simultaneously leveraging quantum computing and semiconductor manufacturing to support the People's Liberation Army. The Committee specifically highlighted GGV Capital's investment in Megvii, a Chinese AI company that actively supports Chinese government efforts to profile and track Uyghurs—language the Committee characterized as "ushering in a new era of automated racism." Qualcomm Ventures' backing of Zongmu, a self-driving vehicle company operating within an industrial park explicitly focused on "military-civilian integration," was flagged as another problematic deployment of U.S. capital.

Data on investment volume underscores the scale of the issue. GSR Ventures emerged as one of the top U.S.-based investors in PRC artificial intelligence companies between 2015 and 2021, according to findings cited by the Committee referencing a Center for Security and Emerging Technology report. Walden International's exposure was equally significant: at least 39% of the firm's AI investments during the same period were directed toward PRC companies. The Committee emphasized that these transactions not only finance technology development contrary to U.S. national interests but also risk transferring critical technical know-how and expertise from American investors to Chinese entities.

The letters represent an escalation of congressional oversight into venture capital's role in funding dual-use technologies with explicit military applications. Institutional investors and alternative asset managers tracking geopolitical risk and regulatory exposure should monitor the responses from these four firms and potential regulatory actions that may follow, as this inquiry may establish precedent for future scrutiny of capital flows into sensitive technology sectors within strategic competitors' economies.